Topics

FDA frants AstraZeneca’s Farxiga review for treating heart failure

11:16 EST 31 Jan 2020 | Pharmaceutical Technology

Earlier this month, the FDA provided AstraZeneca’s Farxiga (dapagliflozin) with a priority review, accepting a supplemental New Drug Application (sNDA)...
Read More...

The post FDA frants AstraZeneca’s Farxiga review for treating heart failure appeared first on Pharmaceutical Technology.

Original Article: FDA frants AstraZeneca’s Farxiga review for treating heart failure

NEXT ARTICLE

More From BioPortfolio on "FDA frants AstraZeneca’s Farxiga review for treating heart failure"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...